Prevalence, correlates and outcomes of gastric antral vascular ectasia in systemic sclerosis: A eustar case-control study

Journal of Rheumatology

Volumn 41, Issue 1, 2014, Pages 99-105

  Ghrénassia, Etienne ^a   Avouac, Jérome ^a   Khanna, Dinesh ^b   Derk, Chris T ^c   Distler, Oliver ^d   Suliman, Yossra Atef ^d   Airo, Paolo ^e   Carreira, Patricia E ^f   Foti, Rosario ^g   Granel, Brigitte ^h   Berezne, Alice ^a   Cabane, Jean ⁱ   Ingegnoli, Francesca ^j   Rosato, Edoardo ^k   Caramaschi, Paola ^l   Hesselstrand, Roger ^m   Walker, Ulrich A ⁿ   Alegre Sancho, Juan Jose ^o   Zarrouk, Virginie ^p   Agard, Christian ^q   Riccieri, Valeria ^k   Schiopu, Elena ^b   Gladue, Heather ^b   Steen, Virginia D ^r   Allanore, Yannick ^a   more..

^a Paris Descartes University ^*  (France)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^e UNIVERSITY OF BRESCIA   (Italy)

^f HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^g UNIVERSITY OF CATANIA   (Italy)

^h HÔPITAL NORD   (France)

ⁱ HÔPITAL SAINT ANTOINE   (France)

^j UNIVERSITY OF MILAN   (Italy)

^k SAPIENZA UNIVERSITY OF ROME   (Italy)

^l UNIVERSITY HOSPITAL OF VERONA   (Italy)

^m LUND UNIVERSITY   (Sweden)

ⁿ UNIVERSITY OF BASEL   (Switzerland)

^o HOSPITAL UNIVERSITARIO DR PESET   (Spain)

^p BEAUJON HOSPITAL   (France)

^q HÔTEL DIEU   (France)

^r GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

more..

Author keywords

Gave; RNA polymerase III; Scleroderma renal crisis; Systemic sclerosis; Watermelon stomach

Indexed keywords

DNA DIRECTED RNA POLYMERASE III; NUCLEOTIDYLTRANSFERASE INHIBITOR; RNA POLYMERASE III ANTIBODY; UNCLASSIFIED DRUG;

ADULT; AGED; ANEMIA; ARTICLE; BLOOD TRANSFUSION; CASE CONTROL STUDY; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; GASTROSCOPY; HIGH RISK POPULATION; HUMAN; KIDNEY DISEASE; LUNG FIBROSIS; MALE; OUTCOMES RESEARCH; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; SCLERODERMA RENAL CRISIS; STOMACH ANTRUM VASCULAR ECTASIA; SURVIVAL RATE; SYSTEMIC SCLEROSIS;

GAVE; RNA POLYMERASE III; SCLERODERMA RENAL CRISIS; SYSTEMIC SCLEROSIS; WATERMELON STOMACH;

ADULT; AGED; BLOOD TRANSFUSION; CASE-CONTROL STUDIES; COMORBIDITY; ENDOSCOPY, GASTROINTESTINAL; FEMALE; GASTRIC ANTRAL VASCULAR ECTASIA; HEMOSTASIS, SURGICAL; HUMANS; MALE; MIDDLE AGED; PREVALENCE; RISK; SCLERODERMA, SYSTEMIC; YOUNG ADULT;

EID: 84891812975     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.130386     Document Type: Article

References (30)

1. Ward EM, Raimondo M, Rosser BG, Wallace MB, Dickson RD. Prevalence and natural history of gastric antral vascular ectasia in patients undergoing orthotopic liver transplantation. J Clin Gastroenterol 2004;38:898-900.
2. Suit PF, Petras RE, Bauer TW, Petrini JL Jr. Gastric antral vascular ectasia. A histologic and morphometric study of "the watermelon stomach". Am J Surg Pathol 1987;11:750-7.
3. Jabbari M, Cherry R, Lough JO, Daly DS, Kinnear DG, Goresky CA. Gastric antral vascular ectasia: the watermelon stomach. Gastroenterology 1984;87:1165-70.
4. Gostout CJ, Viggiano TR, Ahlquist DA, Wang KK, Larson MV, Balm R. The clinical and endoscopic spectrum of the watermelon stomach. J Clin Gastroenterol 1992;15:256-63.
5. Watson M, Hally RJ, McCue PA, Varga J, Jimenez SA. Gastric antral vascular ectasia (watermelon stomach) in patients with systemic sclerosis. Arthritis Rheum 1996;39:341-6.
6. Marie I, Ducrotte P, Antonietti M, Herve S, Levesque H. Watermelon stomach in systemic sclerosis: its incidence and management. Aliment Pharmacol Ther 2008;28:412-21.
7. Marie I, Levesque H, Ducrotte P, Denis P, Hellot MF, Benichou J, et al. Gastric involvement in systemic sclerosis: a prospective study. Am J Gastroenterol 2001;96:77-83.
8. Laoubi K, Allanore Y, Chaussade S, Kahan A, Wipff J. Estomac pastèque dans la sclérodermie systémique (in French). Watermelon stomach in systemic sclerosis. J Mal Vasc 2010;35:250-3.
9. Hung EW, Mayes MD, Sharif R, Assassi S, Machicao VI, Hosing C, et al. Gastric antral vascular ectasia and its clinical correlates in patients with early diffuse systemic sclerosis in the SCOT trial. J Rheumatol 2013;40:455-60.
10. Ingraham KM, O'Brien MS, Shenin M, Derk CT, Steen VD. Gastric antral vascular ectasia in systemic sclerosis: demographics and disease predictors. J Rheumatol 2010;37:603-7.
11. Walker UA, Tyndall A, Czirjak L, Denton C, Farge-Bancel D, Kowal-Bielecka O, et al. Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database. Ann Rheum Dis 2007;66:754-63.
12. Meier FM, Frommer KW, Dinser R, Walker UA, Czirjak L, Denton CP, et al. Update on the profile of the EUSTAR cohort: an analysis of the EULAR Scleroderma Trials and Research group database. Ann Rheum Dis 2012;71:1355-60.
13. Allanore Y, Meune C, Vonk MC, Airo P, Hachulla E, Caramaschi P, et al. Prevalence and factors associated with left ventricular dysfunction in the EULAR Scleroderma Trial and Research group (EUSTAR) database of patients with systemic sclerosis. Ann Rheum Dis 2010;69:218-21.
14. Desai SR, Veeraraghavan S, Hansell DM, Nikolakopolou A, Goh NS, Nicholson AG, et al. CT features of lung disease in patients with systemic sclerosis: comparison with idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia. Radiology 2004;232:560-7.
15. Goh NS, Desai SR, Veeraraghavan S, Hansell DM, Copley SJ, Maher TM, et al. Interstitial lung disease in systemic sclerosis: a simple staging system. Am J Respir Crit Care Med 2008; 177:1248-54.
16. Cutolo M, Sulli A, Pizzorni C, Accardo S. Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis. J Rheumatol 2000;27:155-60.
17. Wipff J, Allanore Y, Soussi F, Terris B, Abitbol V, Raymond J, et al. Prevalence of Barrett's esophagus in systemic sclerosis. Arthritis Rheum 2005;52:2882-8.
18. Sidhu R, Sanders DS, McAlindon ME. Does capsule endoscopy recognise gastric antral vascular ectasia more frequently than conventional endoscopy? J Gastrointestin Liver Dis 2006;15:375-7.
19. Fuccio L, Mussetto A, Laterza L, Eusebi LH, Bazzoli F. Diagnosis and management of gastric antral vascular ectasia. World J Gastrointest Endosc 2013;5:6-13.
20. Ripoll C, Garcia-Tsao G. The management of portal hypertensive gastropathy and gastric antral vascular ectasia. Dig Liver Dis 2011;43:345-51.
21. Avouac J, Meune C, Ruiz B, Couraud PO, Uzan G, Boileau C, et al. Angiogenic biomarkers predict the occurrence of digital ulcers in systemic sclerosis. Ann Rheum Dis 2012;71:394-9.
22. Singh D, Shill M, Kaur H. The watermelon rectum. J Clin Gastroenterol 2001;33:164-6.
23. Steen VD. Autoantibodies in systemic sclerosis. Semin Arthritis Rheum 2005;35:35-42.
24. Meyer O, De Chaisemartin L, Nicaise-Roland P, Cabane J, Tubach F, Dieude P, et al. Anti-RNA polymerase III antibody prevalence and associated clinical manifestations in a large series of French patients with systemic sclerosis: a cross-sectional study. J Rheumatol 2010;37:125-30.
25. Ceribelli A, Cavazzana I, Airo P, Franceschini F. Anti-RNA polymerase III antibodies as a risk marker for early gastric antral vascular ectasia (GAVE) in systemic sclerosis. J Rheumatol 2010;37:1544.
26. Lecleire S, Ben-Soussan E, Antonietti M, Goria O, Riachi G, Lerebours E, et al. Bleeding gastric vascular ectasia treated by argon plasma coagulation: a comparison between patients with and without cirrhosis. Gastrointest Endosc 2008;67:219-25.
27. Yusoff I, Brennan F, Ormonde D, Laurence B. Argon plasma coagulation for treatment of watermelon stomach. Endoscopy 2002;34:407-10.
28. Novitsky YW, Kercher KW, Czerniach DR, Litwin DE. Watermelon stomach: pathophysiology, diagnosis, and management. J Gastrointest Surg 2003;7:652-61.
29. Lorenzi AR, Johnson AH, Davies G, Gough A. Gastric antral vascular ectasia in systemic sclerosis: complete resolution with methylprednisolone and cyclophosphamide. Ann Rheum Dis 2001;60:796-8.
30. Schulz SW, O'Brien M, Maqsood M, Sandorfi N, Del Galdo F, Jimenez SA. Improvement of severe systemic sclerosis-associated gastric antral vascular ectasia following immunosuppressive treatment with intravenous cyclophosphamide. J Rheumatol 2009;36:1653-6.